相关实验视频

Updated: Jun 14, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

CD47作为癌症免疫治疗中的有效标:一篇综述

Hiva Ahvati¹, Raheleh Roudi², Navid Sobhani³

¹School of Biology, College of Science, University of Tehran, Tehran, Iran.

Biochimica et biophysica acta. Reviews on cancer

|March 8, 2025

概括

分化47集群 (CD47) 在癌细胞上过度表达,使他们能够逃避免疫检测. 阻止CD47可能会激活免疫细胞以向和破坏瘤,提供一个有前途的新癌症治疗方法.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

癌症是全球主要的死亡原因,现有的治疗方法面临局限性,特别是转移性疾病.
免疫系统可以对抗癌症,但瘤往往会发展出逃避免疫监测的机制.
差异化集群47 (CD47) 是一种经常在癌细胞上过度表达的蛋白质,作为免疫细胞的"不要吃我"信号.

研究的目的:

审查关于CD47在调节细胞通路中的作用的最新发现.
突出CD47作为癌症免疫治疗中的潜在治疗点的重要性.

主要方法:

对研究研究CD47表达和癌症中的功能进行文学综述.
对CD47封锁的免疫学影响的研究分析.

主要成果:

过度表达CD47使得癌细胞能够通过抑制细胞化和免疫细胞激活来逃避免疫攻击.
阻止CD47可以恢复免疫细胞 (包括巨细胞和T细胞) 识别和消除癌细胞的能力.
CD47在与癌症进展相关的各种细胞信号通路中起着至关重要的作用.

结论:

CD47是开发新型癌症免疫疗法的关键目标.
向CD47对克服治疗耐药性和改善转移性癌症的结果具有重大希望.

关键词:

CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 CD47 细胞通道的细胞通道.免疫球蛋白超级家族免疫球蛋白超级家族癌症治疗疗法癌症治疗

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...